Insider trades

Albers Jeffrey W., Director of Kymera Therapeutics KYMR, has filed 0 purchases and 52 sales on the open market. Over the past 12 months that comes to a net sale of $744.8K. The latest trade was on 06/24.

Albers Jeffrey W.

Director
First filing
23/03/08
Trades
134 trades
Buys / sales
0 / 52
12-month net buying
−$744.8K
Last trade
06/24

Trading activity

Transactions

Trade type
KYMR
Open-market sale10b5-1 plan25/12/0825/12/085,000 sh2 trades$89.76avg.$448,806.96−100.0%
Open-market sale10b5-1 plan25/10/1325/10/145,000 sh$59.19$295,950−100.0%
Open-market sale10b5-1 plan25/06/0325/06/036,349 sh$49.00$311,101−100.0%
Open-market sale10b5-1 plan25/05/2725/05/295,000 sh2 trades$101.14avg.$505,691.5−3.3%
Open-market sale25/03/0525/03/175,766 sh$88.80$512,020.8−3.8%
Open-market sale10b5-1 plan25/03/1225/03/147,500 sh2 trades$87.80avg.$658,500−4.7%
Open-market sale10b5-1 plan25/01/2125/01/2315,161 sh3 trades$109.53avg.$1,660,510.71−9.0%
Open-market sale10b5-1 plan25/01/1325/01/155,000 sh$102.28$511,400−3.1%
Open-market sale10b5-1 plan24/12/1924/12/2015,000 sh4 trades$89.77avg.$1,346,615.4−8.7%
Open-market sale10b5-1 plan24/11/0724/11/125,000 sh$102.00$510,000−3.1%
Open-market sale10b5-1 plan24/11/0624/11/086,700 sh$36.76$246,292−19.7%
Open-market sale10b5-1 plan24/10/2524/10/28300 sh$36.43$10,929−0.9%
Open-market sale10b5-1 plan24/09/0924/09/1119,702 sh2 trades$85.57avg.$1,685,890.56−11.1%
Open-market sale10b5-1 plan24/08/2624/08/265,000 sh$49.10$245,500−100.0%
Open-market sale24/03/0724/03/2611,033 sh$90.69$1,000,582.77−6.3%
Open-market sale10b5-1 plan24/03/2024/03/2225,073 sh5 trades$87.28avg.$2,188,264.5−12.5%
KYMR
Open-market sale10b5-1 plan24/02/20–24/02/2124/02/215,000 sh2 trades$39.05avg.$195,262.3−100.0%
Open-market sale10b5-1 plan24/01/2524/01/2925,000 sh4 trades$81.91avg.$2,047,800−12.4%
Open-market sale10b5-1 plan24/01/2324/01/2310,000 sh$30.05$300,500−100.0%
Open-market sale10b5-1 plan23/12/1123/12/135,000 sh$79.07$395,350−2.8%